Additionally, as many of the protein targets discovered have strong associations to poorly understood disease mechanisms (e.g., APP in Alzheimer's disease and fat mass and obesity‐associated protein [FTO] in obesity), the installation and function of these modifications could play important roles in, or yield information about, the pathogenesis of these diseases. This evidence concerns the gene FTO and early-onset autosomal dominant Alzheimer disease.